Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Fareva
Fareva
Activities:
Manufacturing
Ingredients
X
LinkedIn
Trending Articles
Optimising RNA production for faster and cheaper pharmaceutical manufacturing
RNA production can be a lengthy and complex process, but the Ntensify platform could change this by diminishing development times, decreasing production costs and allowing the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Owlstone Medical bags $6.5m to optimise infectious disease diagnostic tool
The Bill & Melinda Gates Foundation has funded the bolstering of the Breath Biopsy platform, as well as research into breath biomarkers in tuberculosis (TB) and HIV
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Drug Delivery
Fareva completes high potency drug investment
The program started in 2016 at the site of Fareva La Vallée
Manufacturing
Abionyx signs partnership with GTP Biologic and V-Nano
GTP Biologics is part of the Fareva Group, while V-Nano is part of the VBI Therapeutics Group
Regulatory
To comply with EU FMD Fareva selects TraceLink
The API CDMO has selected the track and trace network provider, so that it can successfully connect with its pharmaceutical customers
Containment
Fareva acquires former Merck API manufacturing facility
Acquisition adds another world-class facility to the company's pool of 35 facilities in 11 countries
Subscribe now